JP2008511668A5 - - Google Patents

Download PDF

Info

Publication number
JP2008511668A5
JP2008511668A5 JP2007530352A JP2007530352A JP2008511668A5 JP 2008511668 A5 JP2008511668 A5 JP 2008511668A5 JP 2007530352 A JP2007530352 A JP 2007530352A JP 2007530352 A JP2007530352 A JP 2007530352A JP 2008511668 A5 JP2008511668 A5 JP 2008511668A5
Authority
JP
Japan
Prior art keywords
methyl
imidazo
tetrahydro
pyridin
quinolinamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007530352A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008511668A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/031098 external-priority patent/WO2006028896A2/en
Publication of JP2008511668A publication Critical patent/JP2008511668A/ja
Publication of JP2008511668A5 publication Critical patent/JP2008511668A5/ja
Pending legal-status Critical Current

Links

JP2007530352A 2004-09-02 2005-08-31 化合物 Pending JP2008511668A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60674204P 2004-09-02 2004-09-02
US61076504P 2004-09-17 2004-09-17
PCT/US2005/031098 WO2006028896A2 (en) 2004-09-02 2005-08-31 Chemical compounds

Publications (2)

Publication Number Publication Date
JP2008511668A JP2008511668A (ja) 2008-04-17
JP2008511668A5 true JP2008511668A5 (https=) 2008-10-16

Family

ID=36000724

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007530353A Pending JP2008511669A (ja) 2004-09-02 2005-08-28 化合物
JP2007530352A Pending JP2008511668A (ja) 2004-09-02 2005-08-31 化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2007530353A Pending JP2008511669A (ja) 2004-09-02 2005-08-28 化合物

Country Status (16)

Country Link
US (2) US20070254910A1 (https=)
EP (2) EP1799671A4 (https=)
JP (2) JP2008511669A (https=)
KR (2) KR20070049682A (https=)
AR (2) AR050302A1 (https=)
AU (2) AU2005279835A1 (https=)
BR (1) BRPI0514881A (https=)
CA (2) CA2578746A1 (https=)
IL (1) IL181419A0 (https=)
MA (1) MA28872B1 (https=)
MX (2) MX2007002679A (https=)
NO (2) NO20071366L (https=)
PE (2) PE20060712A1 (https=)
RU (2) RU2351592C2 (https=)
TW (2) TW200621754A (https=)
WO (2) WO2006026703A2 (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008511669A (ja) * 2004-09-02 2008-04-17 スミスクライン ビーチャム コーポレーション 化合物
PE20070946A1 (es) * 2006-01-25 2007-10-16 Smithkline Beecham Corp COMPUESTOS DERIVADOS DE IMIDAZO[1,2-a]PIRIDINA COMO MODULADORES DEL RECEPTOR DE QUIMIOQUINA (CXCR4)
EP2042503B1 (en) 2006-05-16 2013-01-30 Ono Pharmaceutical Co., Ltd. Compound having acidic group which may be protected, and use thereof
WO2008016006A1 (fr) 2006-07-31 2008-02-07 Ono Pharmaceutical Co., Ltd. Composé auquel un groupe cyclique est lié par une liaison spiro et son utilisation
US7767826B2 (en) * 2007-10-05 2010-08-03 Pharmatech International, Inc. Process for the synthesis of L-(+)-ergothioneine
EP2217069A4 (en) * 2007-11-09 2012-03-14 Salk Inst For Biological Studi INHIBITORS OF NON-NUCLEOSIDE INHIBITORS OF THE REVERSE TRANSCRIPTASE
CN102675305B (zh) * 2011-03-08 2014-11-12 中国科学院上海药物研究所 一类咪唑并吡啶类化合物及其制备方法和用途
CN103570683B (zh) * 2012-07-30 2018-04-17 中国科学院上海药物研究所 多取代胺类化合物及其制备方法和用途
MX373103B (es) 2014-02-13 2020-04-17 Incyte Holdings Corp Ciclopropilaminas como inhibidores de desmetilasa específica de lisina 1 (lsd1).
SI3105218T1 (sl) 2014-02-13 2019-11-29 Incyte Corp Ciklopropilamini kot inhibitorji LSD1
WO2016007722A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
EP3277689B1 (en) 2015-04-03 2019-09-04 Incyte Corporation Heterocyclic compounds as lsd1 inhibitors
LT3334709T (lt) 2015-08-12 2025-03-10 Incyte Holdings Corporation Lsd1 inhibitoriaus druskos
WO2017106332A1 (en) 2015-12-14 2017-06-22 X4 Pharmaceuticals, Inc. Methods for treating cancer
CN109069426B (zh) 2015-12-14 2021-10-29 X4 制药有限公司 治疗癌症的方法
KR102738306B1 (ko) * 2015-12-15 2024-12-03 브리스톨-마이어스 스큅 컴퍼니 Cxcr4 수용체 길항제
PL3393468T3 (pl) 2015-12-22 2023-01-23 X4 Pharmaceuticals, Inc. Metody leczenia niedoboru odporności
US11337969B2 (en) 2016-04-08 2022-05-24 X4 Pharmaceuticals, Inc. Methods for treating cancer
WO2017223243A1 (en) 2016-06-21 2017-12-28 X4 Pharmaceuticals, Inc. Cxcr4 inhibitors and uses thereof
CN109640988A (zh) 2016-06-21 2019-04-16 X4 制药有限公司 Cxcr4抑制剂及其用途
ES2870920T3 (es) 2016-06-21 2021-10-28 X4 Pharmaceuticals Inc Inhibidores de CXCR4 y usos de los mismos
EP3585387A4 (en) 2017-02-21 2020-08-12 Emory University CHEMIOKIN CXCR4 RECEIVER MODULATORS AND THEIR USES
JP7282786B2 (ja) * 2017-09-25 2023-05-29 シージーンテック （スーチョウ， チャイナ） カンパニー リミテッド Ｃｘｃｒ４阻害剤としてのヘテロアリール化合物、それを用いた組成物及び方法
KR102678977B1 (ko) * 2017-09-25 2024-06-28 씨젠테크 (쑤저우, 차이나) 컴퍼니 리미티드 Cxcr4 저해제로서 헤테로아릴 화합물, 그 조성물 및 이용 방법
US11649235B2 (en) 2018-03-19 2023-05-16 Emory University Pan-tropic entry inhibitors
US10548889B1 (en) 2018-08-31 2020-02-04 X4 Pharmaceuticals, Inc. Compositions of CXCR4 inhibitors and methods of preparation and use
WO2020047198A1 (en) 2018-08-31 2020-03-05 Incyte Corporation Salts of an lsd1 inhibitor and processes for preparing the same
CA3171250A1 (en) 2020-03-10 2021-09-16 E. Lynne KELLEY Methods for treating neutropenia

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225152A (en) * 1987-07-17 1990-04-26 Janssen Pharmaceutica Nv Heterocyclically substituted piperidinyl benzamides as pharmaceuticals
JP2004512336A (ja) * 2000-09-15 2004-04-22 アノーメッド　インコーポレイティド ケモカインレセプター結合複素環式化合物
PT1317451E (pt) * 2000-09-15 2006-12-29 Anormed Inc Compostos heterocíclicos que se ligam a receptores de quimioquinas
US6835731B2 (en) * 2000-09-15 2004-12-28 Anormed, Inc. Chemokine receptor binding heterocyclic compounds
CA2419224A1 (en) * 2000-09-15 2002-03-21 Anormed Inc. Chemokine receptor binding heterocyclic compounds
CA2467718C (en) * 2001-12-21 2011-04-26 Anormed Inc. Chemokine receptor binding heterocyclic compounds with enhanced efficacy
EP1613613B1 (en) * 2003-04-11 2021-06-02 Genzyme Corporation Cxcr4 chemokine receptor binding compounds
JP2008511669A (ja) * 2004-09-02 2008-04-17 スミスクライン ビーチャム コーポレーション 化合物
WO2006036816A2 (en) * 2004-09-24 2006-04-06 Smithkline Beecham Corporation Chemical compounds
EP1919872A4 (en) * 2005-08-31 2009-08-05 Smithkline Beecham Corp CHEMICAL COMPOUNDS

Similar Documents

Publication Publication Date Title
JP2008511668A5 (https=)
RU2351592C2 (ru) Производные тетрагидрохинолина и фармацевтическая композиция на их основе для лечения и профилактики вич-инфекции
JP2008510006A5 (https=)
JP2008511669A5 (https=)
RU2632900C2 (ru) Гетероциклические амины и их применение
CA2228370C (en) Piperazino derivatives as neurokinin antagonists
RU2486188C2 (ru) СОЕДИНЕНИЯ ИМИДАЗО-[1,2-b]-ПИРИДАЗИНА (ВАРИАНТЫ), СПОСОБ ПОЛУЧЕНИЯ СОЕДИНЕНИЙ ИМИДАЗО-[1,2-b]-ПИРИДАЗИНА (ВАРИАНТЫ), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И ЛЕКАРСТВЕННОЕ СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ И/ИЛИ ПРЕДУПРЕЖДЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С ИНГИБИРОВАНИЕМ ГАМКА РЕЦЕПТОРОВ
RU2004117156A (ru) Амид замещенные имидазопиридины
RS60312B1 (sr) Jedinjenja indol karboksamida korisna kao inhibitori kinaze
US20030191143A1 (en) Fused heterocyclic compounds and use thereof
TW201819386A (zh) Shp2磷酸酶抑制劑及其使用方法
RU2015106787A (ru) Замещенные пирролы, активные в качестве ингибиторов киназ
RU2004106783A (ru) Производные 4-амино-6-фенилпирроло[2, 3] пиримидина
JP2005511745A5 (https=)
JP2008525502A (ja) 抗炎症薬
JP2004511483A (ja) Ｈｉｖインテグラーゼ阻害薬として有用なアザ−およびポリアザ−ナフタレニルカルボキサミド類
CN103936690A (zh) 氨基二氢噻嗪衍生物
RU2005136130A (ru) Новые антагонисты р2х7 рецепторов и их применение
JP2003300959A5 (https=)
KR20090106604A (ko) 축합 피리딘 화합물
JP2008509187A5 (https=)
JP2005524609A5 (https=)
TW201225957A (en) Glycine transporter inhibitor
RS59707B1 (sr) Derivati karbazola
JP2007217408A (ja) 医薬組成物